WILMINGTON, Del.--(BUSINESS WIRE)-- The National Association for Female Executives (NAFE) today named AstraZeneca (NYSE: AZN) one of the top 50 companies for female executives for the fourth consecutive year.
NAFE recognizes organizations for policies and practices that encourage women’s advancement, and in particular, the number of women holding executive positions in the business.
Within AstraZeneca, women lead key teams and functions, including the executive vice president, human resources and corporate affairs; chief operating officer, US; vice president, human resources, US; vice president, sales and marketing, Cornerstone brands; regional vice president of supply, Americas; and vice president, sales and marketing, Growth brands. All US-based women representing US or global functions were considered in the total submission on behalf of AstraZeneca.
“Our goal is to encourage women to capitalize upon their talent and to ultimately reach their career goals and aspirations,” said Deb Kauffman, vice president, Human Resources, US. “This recognition showcases AstraZeneca’s continued commitment to our diverse talent pool.”
AstraZeneca offers programs that contribute to a supportive working culture for women, including:
- Career development and mentoring programs, including support for women’s advancement
- Diverse employee network groups, including the “AZ Network of Women”
- Work/life resource and employee assistance programs providing confidential, personal support, resources and referrals to help solve a wide range of personal and work-related challenges
The National Association for Female Executives (NAFE), founded in 1972, serves 20,000 members nationwide with networking, tools and solutions to strengthen and grow their careers and businesses. NAFE magazine publishes the annual Top Companies issue and the annual Women of Excellence issue. NAFE.com provides up-to-date information, community for women in business and access to member benefits. NAFE is a division of Working Mother Media and Bonnier Corporation.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).
Tony Jewell, 302-885-4594
KEYWORDS: United States North America Delaware
INDUSTRY KEYWORDS: Women Health Biotechnology Pharmaceutical Consumer General Health